Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

68.75
+2.924.44%
Post-market: 68.810.0611+0.09%19:30 EDT
Volume:24.34K
Turnover:1.66M
Market Cap:102.06M
PE:- -
High:68.87
Open:66.43
Low:66.35
Close:65.83
52wk High:74.19
52wk Low:40.17
Shares:1.48M
Float Shares:1.48M
Volume Ratio:0.38
T/O Rate:1.64%
Dividend:0.65
Dividend Rate:0.95%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Dow Jones
·
Sep 30

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

THOMSON REUTERS
·
Sep 30

Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website

THOMSON REUTERS
·
Sep 30

Moderna Appoints Juan Andres as Chief Operating Officer

Reuters
·
Sep 30

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Dow Jones
·
Sep 30

Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60

THOMSON REUTERS
·
Sep 30

Moderna sinks 4% to $195.42 after Citi downgrades to Sell

TIPRANKS
·
Sep 30

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

Stock News
·
Sep 30

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Dow Jones
·
Sep 30

Twist Bioscience (TWST) Gets a Buy from Leerink Partners

TIPRANKS
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)

TIPRANKS
·
Sep 29

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

Stock News
·
Sep 29

Pfizer, Moderna Lose Bids to Escape Bayer US mRNA Patent Lawsuit

Reuters
·
Sep 29

Guardant Health (GH) Receives a Buy from Bernstein

TIPRANKS
·
Sep 26

Natera (NTRA) Receives a Buy from Bernstein

TIPRANKS
·
Sep 26

Twist Bioscience CEO Emily M. Leproust Disposes of 5,203 Common Shares Worth $921,493.96

Reuters
·
Sep 26

NASDAQ New 52-Week Highs and Lows

Dow Jones
·
Sep 26

Innovation is Driving a New Bull Market in Biotech. 16 Ways to Play It, from Our Roundtable Experts.

Dow Jones
·
Sep 25

Natera's Signatera Genome Could Emerge as Dominant Clinical Offering Within Few Years, RBC Says

MT Newswires Live
·
Sep 25

Moderna (MRNA) Receives a Hold from Bernstein

TIPRANKS
·
Sep 25